Bourougaa Lotfi

Dr. Bourougaa Lotfi

orcid
Unexpected vanillin derivatives featuring a 1,3-dithiol frag

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 March 2024 in Journal of Molecular Structure
Verified
Journal Article
Closed access
NANasrin Akter
Nasrin Akter
Bourougaa LotfiBourougaa Lotfi
Bourougaa Lotfi
MOMebarka Ouassaf
Mebarka Ouassaf
RBRipon C. Bhowmic
Ripon C. Bhowmic
KUKabir M. Uddin
Kabir M. Uddin
Sarkar M.A. KawsarSarkar M.A. Kawsar
Sarkar M.A. Kawsar

10 March 2024 in Molecules
Verified
Journal Article
Open access
PDF file
YCYassmine Hind Chennai
Yassmine Hind Chennai
SBSalah Belaidi
Salah Belaidi
Bourougaa LotfiBourougaa Lotfi
Bourougaa Lotfi
OMOuassaf Mebarka
Ouassaf Mebarka
LSLeena Sinha
Leena Sinha
SCSamir Chtita
Samir Chtita
Huperzine A (HUP) plays a crucial role in Alzheimer’s therapy by enhancing cognitive function through increased cholinergic activity as a reversible acetylcholinesterase (AChE) inhibitor. Despite some limitations being seen in AChE inhibitors, ongoing research remains dedicated to finding innovative and more effective treatments for Alzheimer’s disease. To achieve the goal of the discovery of potential HUP analogues with improved physicochemical properties, less toxic properties, and high biological activity, many in silico methods were applied. Based on the acetylcholinesterase–ligand complex, an e-pharmacophore model was developed. Subsequently, a virtual screening involving a collection of 1762 natural compounds, sourced from the PubChem database, was performed. This screening yielded 131 compounds that exhibited compatibility with the established pharmacophoric hypothesis. These selected ligands were then subjected to molecular docking within the active site of the 4EY5 receptor. As a result, we identified four compounds that displayed remarkable docking scores and exhibited low free binding energy to the target. These top four compounds, CID_162895946, CID_44461278, CID_44285285, and CID_81108419, were submitted to ADMET prediction and molecular dynamic simulations, yielding encouraging findings in terms of their pharmacokinetic characteristics and stability. Finally, the molecular dynamic simulation, cross-dynamic correlation matrix, free energy landscape, and MM-PBSA calculations demonstrated that two ligands from the selected ligands formed very resilient complexes with the enzyme acetylcholinesterase, with significant binding affinity. Therefore, these two compounds are recommended for further experimental research as possible (AChE) inhibitors.

28 February 2024 in Journal of Molecular Modeling
Verified
Journal Article
Closed access
PDF file
RBRidha Bendaas
Ridha Bendaas
YBYahia Bekkar
Yahia Bekkar
LMLyamine Messaadia
Lyamine Messaadia
Bourougaa LotfiBourougaa Lotfi
Bourougaa Lotfi
AMAbdelatif Messaoudi
Abdelatif Messaoudi
BMBenamira Messaoud
Benamira Messaoud

19 June 2023 in Journal of Biomolecular Structure and Dynamics
Verified
Journal Article
Closed access
Bourougaa LotfiBourougaa Lotfi
Bourougaa Lotfi
OMOuassaf Mebarka
Ouassaf Mebarka
SKShafi Ullah Khan
Shafi Ullah Khan
Thet Thet HtarThet Thet Htar
Thet Thet Htar
The in silico evaluation of 27 p-aminosalicylic acid derivatives, also referred to as neuraminidase inhibitors was the focus of the current study. To search and predict new potential neuraminidase inhibitors, this study was based on the ligand-based pharmacophore modeling, 3D QSAR, molecular docking, ADMET and MD simulation studies. The data was generated from recently reported inhibitors and divided into two groups, one of these group has 17 compounds for training and the second group has 10 compounds for testing purpose. The generated pharmacophore has known as ADDPR_4 was found statistically significant 3D-QSAR model owing the high trust scores (R2 = 0.974, Q2 = 0.905, RMSE = 0.23). Morever external validation was also employed to evaluate the prediction capacity of the built pharmacophore model (R2pred = 0.905). In addition, in silico ADMET, analyses were employed to evaluate the obtained hits for drug likeness properties. The stability of formed complexes was further evaluated using molecular dynamics. Top two hits showed stable complexes with Neuraminidase based on calculated total binding energy by MM-PBSA.Communicated by Ramaswamy H. Sarma.

13 December 2023 in Molecules
Verified
Journal Article
Open access
PDF file
OMOuassaf Mebarka
Ouassaf Mebarka
Bourougaa LotfiBourougaa Lotfi
Bourougaa Lotfi
SASamiah Hamad Al-Mijalli
Samiah Hamad Al-Mijalli
Emad M. AbdallahEmad M. Abdallah
Emad M. Abdallah
ABAJMAL R BHAT
AJMAL R BHAT
Sarkar M.A. KawsarSarkar M.A. Kawsar
Sarkar M.A. Kawsar
Marine compounds constitute a diverse and invaluable resource for the discovery of bioactive substances with promising applications in the pharmaceutical development of anti-inflammatory and antibacterial agents. In this study, a comprehensive methodology was employed, encompassing pharmacophore modeling, virtual screening, in silico ADMET assessment (encompassing aspects of absorption, distribution, metabolism, excretion, and toxicity), and molecular dynamics simulations. These methods were applied to identify new inhibitors targeting the Hsp90 protein (heat shock protein 90), commencing with a diverse assembly of compounds sourced from marine origins. During the virtual screening phase, an extensive exploration was conducted on a dataset comprising 31,488 compounds sourced from the CMNPD database, characterized by a wide array of molecular structures. The principal objective was the development of structure-based pharmacophore models, a valuable approach when the pool of known ligands is limited. The pharmacophore model DDRRR was successfully constructed within the active sites of the Hsp90 crystal structure. Subsequent docking studies led to the identification of six compounds (CMNPD 22591, 9335, 10015, 360799, 15115, and 20988) demonstrating substantial binding affinities, each with values below −8.3 kcal/mol. In the realm of in silico ADMET predictions, five of these compounds exhibited favorable pharmacokinetic properties. Furthermore, molecular dynamics simulations and total binding energy calculations using MM-PBSA indicated that these marine-derived compounds formed exceptionally stable complexes with the Hsp90 receptor over a 100-nanosecond simulation period. These findings underscore the considerable potential of these novel marine compounds as promising candidates for anticancer and antimicrobial drug development.

12 January 2025 in Applied Organometallic Chemistry
Verified
Journal Article
Closed access
AAAicha Adaika
Aicha Adaika
YBYahia Bekkar
Yahia Bekkar
SYSouhir Youmbai
Souhir Youmbai
Bourougaa LotfiBourougaa Lotfi
Bourougaa Lotfi
LELANEZ Elhafnaoui
LANEZ Elhafnaoui
LBLazhar Bechki
Lazhar Bechki